Physician profile
Daniel Cibulsky
NPI 1427311729
$16,561.89
in general payments reported to CMS, 2019-2025
28 companies · $828 in 2025
The $828 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $240 · 2021: $39.88 · 2022: $102 · 2023: $11K · 2024: $3,472 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $5,062 · Food and Beverage: $2,060 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $5,061.65 |
| Food and Beverage | $2,059.51 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,423.83 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Kerecis Limited | $340.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $321.02 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Abbvie INC. | $222.76 | 2019-2020 | |
| Astellas Pharma US INC | $182.29 | 2019-2025 | Veozah |
| Avion Pharmaceuticals | $135.62 | 2019-2021 | |
| Hologic Sales and Service, LLC | $131.14 | 2021-2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $106.02 | 2019-2025 | |
| Exact Sciences Corporation | $78.84 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $68.21 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $62.75 | 2025 | Myfembree |
| Applied Medical Resources Corporation | $61.44 | 2023 | Gelpoint V-Path |
| Organon LLC | $58.90 | 2022-2024 | Nexplanon |
| Pfizer INC. | $47.49 | 2019 | |
| Exeltis, USA INC. | $44.19 | 2025 | Slynd |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $39.59 | 2019 | |
| Allergan, INC. | $32.92 | 2019-2020 | |
| Richard Wolf Medical Instruments Corp. | $29.97 | 2023 | |
| Merck Sharp & Dohme LLC | $29.30 | 2019 | |
| Biogen, INC. | $23.46 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $21.40 | 2025 | |
| Lupin INC. | $19.56 | 2019 | |
| Daiichi Sankyo INC. | $17.20 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.72 | 2019 | |
| Duchesnay USA Incorporated | $13.60 | 2019 | |
| Millicent US INC | $12.35 | 2019 | |
| Mission Pharmacal Company | $11.72 | 2020 | |
| Medicem INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cibulsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.